MedPath

Study to compare between Levobupivacaine and Ropivacaine in infra-umbilical surgeries for epidural anaesthesia

Phase 4
Registration Number
CTRI/2023/06/054380
Lead Sponsor
Dr Shreya Putta
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients undergoing a given Infra umbilical surgeries giving consent to participate in study. Age between 18 to 60 years. ASA grade I and grade II

Exclusion Criteria

Patients not giving consent to participate in the study.

ASA grade III and IV

Patients with respiratory, cardiovascular, hepatic and renal diseases, obesity.

Age below <18 years and above >60 years.

Any bleeding disorder and patient on anticoagulants.

Neurological and musculoskeletal disease.

Local infection at the injection site.

History of hypersensitivity or allergy to any drug

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expected early onset of sensory & motor blockade & prolonged duration of analgesia with epidural ropivacaine 0.75%Timepoint: 24 hours
Secondary Outcome Measures
NameTimeMethod
Expected stable haemodynamic profile & lesser side effects with epidural levobupivacaine 0.5%Timepoint: 24 hours
© Copyright 2025. All Rights Reserved by MedPath